Matching articles for "Tranderm Scop"

In Brief: Hyperthermia with Scopolamine Patches

   
The Medical Letter on Drugs and Therapeutics • August 18, 2025;  (Issue 1735)
The FDA has required a new warning in the label for the scopolamine transdermal patch (Transderm-Scōp, and generics) about a risk of serious or fatal hyperthermia. Scopolamine, an anticholinergic drug, is...
The FDA has required a new warning in the label for the scopolamine transdermal patch (Transderm-Scōp, and generics) about a risk of serious or fatal hyperthermia. Scopolamine, an anticholinergic drug, is FDA-approved for prevention of nausea and vomiting associated with motion sickness or recovery after surgery in adults; it is often used off-label to reduce drooling in children and adolescents with neurologic disorders.
Med Lett Drugs Ther. 2025 Aug 18;67(1735):136 | Show Full IntroductionHide Full Introduction